Rapamycin recruits SIRT2 for FKBP12 deacetylation during mTOR activity modulation in innate immunity
Lin Hu(Soochow University), Y. Eugene Chin(Rhode Island Hospital), Jian-chuan Wang(Boston Children's Hospital), Fuxian Chen(Soochow University), Linpeng Wu(Soochow University), Chao‐Liang Wu(Wannan Medical College), Hui Zheng(Hunan University), Wei Deng(Hunan University), Yu Sun(Dalian Medical University), Sisi Chen(Chinese Academy of Sciences), Xiangrong Li(State Ethnic Affairs Commission), Jun Wang(Rutgers Sexual and Reproductive Health and Rights), Zhijie Chang(Tsinghua University), Yu Rao(Soochow University), Jianping Ding(Center for Excellence in Molecular Cell Science), Chao Huang(Union Hospital), Jing Wang(Inserm), Cheng Luo(Central South University)
Cited by 15
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
|Science Advances|2020|400
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
The role of macrophages in osteoarthritis and cartilage repair
|Osteoarthritis and Cartilage|2020|332